About Tinea Pedis Treatment Tinea pedis, also known as athlete’s foot, is caused by dermatophyte fungus on foot and can spread to toenails and hands. It is a dermatophyte infection of the soles of the feet and the interdigital spaces. Tinea pedis thrives in warm, humid conditions and is most common among young adult men. Tinea pedis can be transmitted through direct contact with an infected person or by touching surfaces contaminated with the fungus. This fungus lives in warm, moist environments and is found in showers, locker room floors, and swimming pools. Technavio’s analysts forecast the global tinea pedis treatment market to grow at a CAGR of 3.03% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global tinea pedis treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs sales. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Tinea Pedis Treatment... Research Beam Model: Research Beam Product ID: 1625359 3500 USD New
Global Tinea Pedis Treatment Market 2017-2021
 
 

Global Tinea Pedis Treatment Market 2017-2021

  • Category : Healthcare
  • Published On : June   2017
  • Pages : 71
  • Publisher : Technavio
 
 
 
About Tinea Pedis Treatment
Tinea pedis, also known as athlete’s foot, is caused by dermatophyte fungus on foot and can spread to toenails and hands. It is a dermatophyte infection of the soles of the feet and the interdigital spaces. Tinea pedis thrives in warm, humid conditions and is most common among young adult men. Tinea pedis can be transmitted through direct contact with an infected person or by touching surfaces contaminated with the fungus. This fungus lives in warm, moist environments and is found in showers, locker room floors, and swimming pools.

Technavio’s analysts forecast the global tinea pedis treatment market to grow at a CAGR of 3.03% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global tinea pedis treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs sales.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Tinea Pedis Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• GSK
• Exeltis USA
• Valeant
• Viamet Pharmaceuticals

Other prominent vendors
• Allergan
• Almirall
• Amgen
• Aqua Pharmaceuticals
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Celgene
• Dermira
• Elorac
• F. Hoffmann-La Roche
• Galderma
• Genentech
• Hexima
• Hisamitsu Pharmaceutical
• Incyte
• Mayne Pharma
• MediQuest Therapeutics
• Meiji Seika Pharma
• Merz Pharmaceuticals
• Moberg Pharma
• Mylan Pharmaceuticals
• NanoBio
• NovaBiotics
• Novan
• Nuvo Research
• Polichem
• Promius Pharma
• Sanofi
• Seren Pharmaceuticals
• Sun Pharma
• Taro
• Teva Pharmaceutical
• Theravance Biopharma
• Tinea Pharmaceuticals
Market driver
• High unmet needs
• For a full, detailed list, view our report

Market challenge
• Increased availability of generics and alternative therapies
• For a full, detailed list, view our report

Market trend
• Increased funding for antifungal research
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Pipeline landscape
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by ROA
• Oral
• Topical
PART 08: Market segmentation by disease type
• Interdigital tinea pedis
• Vesicular tinea pedis
PART 09: Geographical segmentation
• Tinea pedis treatment market in Americas
• Tinea pedis treatment market in EMEA
• Tinea pedis treatment market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Market challenges
PART 12: Market trends
• Increased funding for antifungal research
• Increased focus on combination therapies
• Advent of novel therapies
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• GSK
• Valeant
• Exeltis USA
• Viamet Pharmaceuticals
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Symptoms of tinea pedis
Exhibit 02: Pipeline analysis
Exhibit 03: Global tinea pedis treatment market: Snapshot
Exhibit 04: Global tinea pedis treatment market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis: Global tinea pedis treatment market
Exhibit 06: Five forces analysis
Exhibit 07: Global tinea pedis treatment market by ROA 2016
Exhibit 08: Global tinea pedis treatment market by disease type 2016
Exhibit 09: Global interdigital tinea pedis treatment market 2016-2021 ($ millions)
Exhibit 10: Global vesicular tinea pedis treatment market 2016-2021 ($ millions)
Exhibit 11: Global tinea pedis treatment market by geography 2016 and 2021
Exhibit 12: Global tinea pedis treatment market by geography 2016-2021 ($ millions)
Exhibit 13: Market scenario in Americas
Exhibit 14: Tinea pedis treatment market in Americas 2016-2021 ($ millions)
Exhibit 15: Market scenario in EMEA
Exhibit 16: Tinea pedis treatment market in EMEA 2016-2021 ($ millions)
Exhibit 17: Market scenario of APAC
Exhibit 18: Tinea pedis treatment market in APAC 2016-2021 ($ millions)
Exhibit 19: Competitive structure analysis of global tinea pedis treatment market 2016
Exhibit 20: Strategic success factors of companies in global tinea pedis treatment market
Exhibit 21: GSK: Strength assessment
Exhibit 22: GSK: Strategy assessment
Exhibit 23: GSK: Opportunity assessment
Exhibit 24: Valeant: Key highlights
Exhibit 25: Valeant: Strength assessment
Exhibit 26: Valeant: Strategy assessment
Exhibit 27: Valeant: Opportunity assessment
Exhibit 28: Exeltis USA: Strength assessment
Exhibit 29: Exeltis USA: Strategy assessment
Exhibit 30: Exeltis USA: Opportunity assessment
Exhibit 31: Viamet Pharmaceuticals: Strength assessment
Exhibit 32: Viamet Pharmaceuticals: Strategy assessment
Exhibit 33: Viamet Pharmaceuticals: Opportunity assessment

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT